Behind the Scenes of Apellis Pharmaceuticals's Latest Options TrendsBenzinga • 5 days ago
read more...
Share to Feed
Latest Ratings for APLS
DateFirmActionFromTo Mar 2022Goldman SachsMaintainsBuy Mar 2022Raymond JamesMaintainsStrong Buy Jan 2022Raymond JamesMaintainsStrong Buy
View More Analyst Ratings for...
WALTHAM, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a grant...
WALTHAM, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the 23rd Annual Needham Virtual...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Crispr Therapeutics AG (CRSP Research Report) and Apellis Pharmaceuticals...
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Apellis Pharmaceuticals (APLS Research Report) and Bluebird Bio...
This is a signal that APLS's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
This is a Bullish indicator signaling APLS's price could rise from here. Traders may explore going long the stock or buying call options...
It has been about a month since the last earnings report for Apellis Pharmaceuticals, Inc. (APLS). Shares have lost about 8.7% in that time frame, underperforming the S&P 500.Will the recent negative...
With the business potentially at an important milestone, we thought we'd take a closer look at Apellis Pharmaceuticals...